RC
Repligen Corporation
RGEN· Health Care· BiotechnologyS&P 400
Close · 16/09/2026
172.91
1D
-1.04%52-week range
100.99 – 188.73
Volume
8,26,900.00
Price history
RGEN
17/08/2026 to 16/09/2026
O 174.90 H 178.55 L 171.66
1W+4.76%
1M+2.29%
3M+31.30%
6M+44.97%
1Y+52.02%
3Y+6.04%
5Y-41.27%
MAX-11.22%
Fundamentals
as of 16/09/2026- Market cap
- $9.76B
- Shares out
- 56.44M
- P/E (trailing)
- 234.92
- P/E (forward)
- 62.33
- EPS (trailing)
- 0.74
- Beta
- 1.05
- Profit margin
- 5.29%
- P/B
- 4.62
- Return on equity
- 1.97%
SEC financial statements
59 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- RGEN
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
2 filers · 0 on watchlist · 3 buys · 4 sells · R: 7
- 31/10/2025Lisa McClainSellRepligen Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainSellRepligen Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 22/07/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 17/06/2025Lisa McClainSell+Repligen Corporation - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 07/04/2025Jefferson ShreveSellRepligen Corporation - Common Stock$15,001–$50,000